Genolution Inc. (225220) — Financial Flexibility Index
Genolution Inc. (225220) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of ₩-847.68 Million (operating CF ₩-927.21 Million minus capex ₩79.52 Million) represents 0% of total liabilities (₩26.44 Billion). Check how strategically is Genolution Inc.'s equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Genolution Inc. Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Genolution Inc. across 9 annual periods. See Genolution Inc. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Genolution Inc. (2016–2024)
Year-by-year free cash flow to debt coverage for Genolution Inc.. For the full company profile including market capitalisation, see Genolution Inc. stock valuation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.41x | ₩10.75 Billion | ₩-1.43 Billion | ₩26.16 Billion | ▲ +85.8% |
| 2023 | 0.22x | ₩5.75 Billion | ₩-1.14 Billion | ₩25.99 Billion | ▼ -87.9% |
| 2022 | 1.83x | ₩36.10 Billion | ₩13.55 Billion | ₩19.75 Billion | ▼ -24.6% |
| 2021 | 2.42x | ₩30.86 Billion | ₩25.73 Billion | ₩12.74 Billion | ▼ -0.3% |
| 2020 | 2.43x | ₩54.65 Billion | ₩45.97 Billion | ₩22.48 Billion | ▲ +756.0% |
| 2019 | 0.28x | ₩3.06 Billion | ₩-80.58 Million | ₩10.79 Billion | ▼ -24.6% |
| 2018 | 0.38x | ₩3.07 Billion | ₩147.49 Million | ₩8.16 Billion | ▼ -83.2% |
| 2017 | 2.24x | ₩1.58 Billion | ₩717.13 Million | ₩704.01 Million | ▲ +288.6% |
| 2016 | 0.58x | ₩329.27 Million | ₩-27.00 Million | ₩570.62 Million | — |